CLINICAL_TRIALS
trial_result
· 2022-01-04
Clinical Trial Update: Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis [Phase 2]
Summary
Phase 2 clinical trial evaluating simvastatin for reducing pancreatitis in patients with acute pancreatitis; study completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Acute Pancreatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-01-04